CEO Q&A with Henry Lees-Buckley at Sativa Group (NEX:SATI)

Sativa Group (NEX:SATI) Chief Executive Officer Henry Lees-Buckley caught up with DirectorsTalk for an exclusive interview to discuss the new appointments in the Group, the progress of the cannabis cultivation project and the company’s admission to AIM.

Q1: Henry, news out on some recent appointments, the first of which being a Product and Procurement Manager. Could you expand on that for us?

A1: Sativa Group is very excited to announce the appointment of Richard Bunce, this will, with Richard’s skill and experience, really take our product management capabilities to a whole new level.

His responsibilities will be to oversee our entire product range, that includes things like product quality, our product compliance, category management, the packaging of all of our products and, most importantly, the expansion of our product range.

So, our intention is to expand the products we offer to all of our customers through each and every brand we have so this is a Sativa-wide initiative, not related to any specific brand but to make sure the quality and compliance etc. is consistent across all of our brands and we’re able to expand our product range in a constituent manner.

So, very pleased to have him on board and he’s already making a big difference.

Q2: The second was for another significant appoint, Director of Retail Sales for Goodbody Botanicals. What’s the plan there?

A2: Goodbody Botanicals is our retail brand so our goal is simply to be the UK’s leading brand on the high street. So, our ambition is to have the Goodbody Botanicals brand available across a number of high street retailers across the UK as soon as we possibly can.

So, we announced earlier our partnership with SHS Distribution who will do our logistics and provide some sales support for us, top shelf firm, highly recognised and respected by all of the high street retailers. So, that was a huge appointment for us in terms of a partner.

Now, the appointment of Alan Horton as the Director of Retail Sales really helps us take this to the next level so we have somebody inside who is also equally focussed on this. Alan will be managing some of our sales team but will also have direct contact with those high street retailers in conjunction with SHS.

So, it’s really just adding some serious horsepower to our high street efforts, at the end of the day, we believe we have a great brand for the high street and now we’ve got a great team with both Alan and SHS really focussed on that effort.

Q3:  You also talk about the progress with the cannabis cultivation project, what can you tell us about that?

A3: Recently, we announced our Home Office licence, which is something we’re extremely proud of, very few companies in the UK have that Home Office Licence. That licence is to grow THC-rich medicinal cannabis, our cannabis product, for medicinal research so it’s really in conjunction with King’s College in London to help and aid their efforts and research.

We kicked that off, we got the Home Office licence and things are progressing very very well. The grow is going exactly as we expected and we’re very proud of the efforts the team has made there to provide King’s College with the product they need for research.

Q4: Just shifting gears, I see that you also plan to move Sativa Group to the London AIM market. How’s that progressing?

A4: Our aim is to definitely be on AIM and do so in the New Year. We’ve enjoyed a very good relationship with the NEX Exchange and we couldn’t thank them enough and we’ve done extremely well with that it.

We heard loud and clear from a number of institutional or intended institutional shareholders, some have the ability and desire to trade on NEX, others don’t, but the message was loud and clear that they’d like to see us on AIM so we’re certainly listening to that.

Quite frankly, that’s our plan. We’ve appointed Cenkos Securities to explore the admission, it’s never a guarantee but we certainly feel we have a very strong case and we’ll plan to work right now and seek admission to the London AIM market early in the New Year.

So, pretty excited about that focus so lots going on here.

Click to view all articles for the EPIC:
Or click to view the full company profile:
    Facebook
    Twitter
    LinkedIn
    Sativa Group

    More articles like this

    Sativa Group

    CBD Oil for Alzheimer’s & Dementia

    Hemp and CBD oil were federally legalized with the 2018 Farm Bill, but scientists have been researching cannabidiol and its potential benefits for many years prior to the cannabis boom. CBD products are gaining popularity at

    Sativa Group

    Why is CBD so popular among athletes and sportspeople?

    Cannabidiol – the cannabis derivative known more commonly by its abbreviated name, ‘CBD – has gained popularity among people from all walks of life. The cannabinoid has been adopted by people of all ages looking for

    Sativa Group

    CBD for anxiety: What you need to know

    A lot of health claims now surround CBD, some of them more substantiated than others. You may have heard that CBD is an effective anxiety medication, but how true is that? In fact, while many sell

    Sativa Group

    William Shatner has said he uses cannabis for medical reasons

    The 89-year-old actor said that he has been taking cannabis extracts such as CBD (cannabidiol) and THC (tetrahydrocannabinol) to help manage pain and swelling in his joints. Speaking to the PA news agency, the Star Trek star said: “I’ve got some aches and pains

    Sativa Group

    Why CBD is growing in popularity in the past few years

    In recent years, the popularity of cannabidiol (CBD) has increased significantly. This compound, which is found in the cannabis plant, has infiltrated society as an effective natural treatment for a wide range of medical conditions. Most

    Sativa Group

    Sativa Group implement new management incentive plan

    Sativa Group Plc (AQSE:SATI), the UK’s leading quoted CBD wellness and medicinal cannabis company, has today announced the implementation of a new management incentive plan to retain and incentivise Henry Lees-Buckley, Chief Executive Officer, and to

    Sativa Group

    Everything You Need to Know About CBD Oil in the UK

    “The hottest new medicine in mental health,” claims a professor in psychiatry at King’s College London. From claims that it treats severe forms of epilepsy to a key ingredient in plant-based restaurants in London; you guessed

    Sativa Group

    Could CBD help with COVID-19?

    Researchers at the University of Lethbridge recently declared the benefits of CBD as a potential aid in blocking the cells that enter the body from COVID-19 after promising results from a study. The study was conducted in

    Sativa Group

    UK demand for CBD products soars amid Pandemic

    While Covid-19 continues to devastate the global economy, there are some businesses for which the pandemic has created opportunities rather than problems. One good example is the UK’s nascent market for cannabidiol (CBD) products, where entrepreneurs

    Sativa Group

    Could CBD help ease your covanxiety?

    The world just won’t stop, will it? Duly, nor will the anxiety, the sleeplessness and the unshakable sense of all being unwell. There is no panacea — unless someone has a secret passage into an alternative reality

    Sativa Group

    Sativa Group enters into a LOI with StillCanna, Inc

    Sativa Group Plc (NEX:SATI), the UK’s leading quoted CBD wellness and medicinal cannabis Group, confirmed that is has today entered into a letter of intent (“LOI”) with StillCanna, Inc, regarding a possible offer for the Company.

    Sativa Group

    Can CBD Help You Sleep?

    CBD is becoming more and more talked about lately for some of its uses in other applications outside of exercise and sports, and we’re seeing more and more reports of it being used at the end

    Sativa Group

    New CBD safety certification initiative launched

    Following the Food Standards Agency (FSA) giving the CBD industry a deadline of March 31, 2021, to submit valid novel food authorisation applications The Association for the Cannabinoid Industry (The ACI) have outlined new plans for The ACI

    Sativa Group

    How much CBD should you take?

    It’s hard to tell with CBD just how much will work for you, and we’re going to explore ways you can ease into finding what works best for you, as well as why CBD is so